文献速递甲状腺疾病

美国对极低风险分化型甲状腺癌积极监测的采纳情况:一项全国性调查

Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究调查了美国内分泌科医生和外科医生对极低风险分化型甲状腺癌积极监测(AS)的采纳情况。在464名受访者中,45.7%为非采纳者;非采纳者在学术机构执业、年接诊甲状腺癌患者超过25例、知晓AS、使用适用指南、知道如何判断患者适合AS、拥有实施AS的资源或使用AS的动机方面均显著低于采纳者。仅3.2%的受访者认为患者知晓AS。结论认为广泛采纳AS需要提高患者和医生的认知、兴趣并评估结局。

要点

  • 非采纳者占45.7%,在学术机构执业、年接诊超过25例甲状腺癌患者、知晓AS、使用指南等方面显著低于采纳者。
  • 非采纳者更可能对AS感到焦虑或保留意见,担心不良结局或认为AS给患者带来心理负担。
  • 仅3.2%的受访者认为患者知晓AS,广泛采纳需提高患者和医生认知。

核心结论

  • 广泛采纳AS需要提高患者和医生的认知、兴趣并评估结局。

研究设计与样本

  • 调查美国医学会Masterfile中的内分泌科医生和外科医生,共464名受访者(应答率33.3%)。
  • 通过2例适合AS的假设病例的治疗推荐来评估采纳情况。

主要发现

  • 仅3.2%的受访者认为患者知晓AS。

临床怎么用

  • 临床医生应提高对AS的认知和判断患者适合性的能力,并获取实施AS的资源。
  • 需加强与患者讨论AS,提高患者对AS的知晓度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Active surveillance (AS) of thyroid cancer with serial ultrasounds is a newer management option in the United States. OBJECTIVE: This work aimed to understand factors associated with the adoption of AS. METHODS: We surveyed endocrinologists and surgeons in the American Medical Association Masterfile. To estimate adoption, respondents recommended treatment for 2 hypothetical cases appropriate for AS. Established models of guideline implementation guided questionnaire development. Outcome measures included adoption of AS (nonadopters vs adopters, who respectively did not recommend or recommended AS at least once; and partial vs full adopters, who respectively recommended AS for one or both cases). RESULTS: The 464 respondents (33.3% response) demographically represented specialties that treat thyroid cancer. Nonadopters (45.7%) were significantly (P < .001) less likely than adopters to practice in academic settings, see more than 25 thyroid cancer patients/year, be aware of AS, use applicable guidelines (P = .04), know how to determine whether a patient is appropriate for AS, have resources to perform AS, or be motivated to use AS. Nonadopters were also significantly more likely to be anxious or have reservations about AS, be concerned about poor outcomes, or believe AS places a psychological burden on patients. Among adopters, partial and full adopters were similar except partial adopters were less likely to discuss AS with patients (P = .03) and more likely to be anxious (P = .04), have reservations (P = .03), and have concerns about the psychological burden (P = .009) of AS. Few respondents (3.2%) believed patients were aware of AS. CONCLUSION: Widespread adoption of AS will require increased patient and physician awareness, interest, and evaluation of outcomes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Pitt SC, Yang N, Saucke MC, et al. Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey. J Clin Endocrinol Metab. 2021. PMID: 33373458. doi:10.1210/clinem/dgaa942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。